[Clinical testing of a new vasoconstrictor agent (POR 8) as an addition to the local anesthetic in operation on the otorhinolaryngologic area].
D000779:Anesthetics, Local; D001794:Blood Pressure / Q000187:drug effects; D004837:Epinephrine / Q000009:adverse effects / Q000627:therapeutic use; D005259:Felypressin / Q000008:administration & dosage; D006487:Hemostasis; D006801:Humans; D007511:Ischemia; D009325:Nausea / Q000139:chemically induced; D010038:Otorhinolaryngologic Diseases / Q000601:surgery*; D010121:Oxytocin / Q000627:therapeutic use; D011674:Pulse / Q000187:drug effects; D013610:Tachycardia / Q000139:chemically induced; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*; D014667:Vasopressins / Q000008:administration & dosage
D000779:Anesthetics, Local; D014662:Vasoconstrictor Agents; D014667:Vasopressins; D010121:Oxytocin; D005259:Felypressin; D004837:Epinephrine
Klinische Prüfung eines neuen Vasokonstriktors (POR 8) als Zustz zur LA bei Eingriffen im ORL-Bereich.